Leading the Way in Life Science Technologies

GEN Exclusives

More »

New Products

Whether you are searching for a DNA purification kit or outfitting a cGMP facility, GEN’s comprehensive new product database is your first and only stop. Conveniently categorized and searchable, the database covers the latest innovations from industry-leading suppliers.

Phenomenex

  • Page 1 of 1 (3 items) 1 

Chiral Selector Column

Phenomenex

The new 3 µm particle size chiral selector, Lux Amylose-1, amylose tris (3,5-dimethylphenylcarbamate) are high-efficiency polysaccharide columns, ideal for UHPLC, HPLC, and SFC chiral screening and analysis. Now with two sizes, the new...

GC Column

Phenomenex

The Zebron™ ZB-5MSPLUS™ is a highly inert 5% phenyl-arylene phase GC column for challenging separations in industries such as food testing, pharmaceutical and clinical research, forensic toxicology, and industrial chemicals. ...

HPLC Columns

Phenomenex

The Amylose-1 chiral stationary phase is being added to the high-efficiency Lux polysaccharide chiral column line. Amylose-1 adds valuable enantioselectivity to the Lux column family with the chiral selector amylose tris (3,5-dimethylphenylcarba...

  • Page 1 of 1 (3 items) 1 

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »